MaGIC-OT:一个人工智能引导的光学笔平台,用于微流体设备中自主单细胞隔离
Jan-Philipp Cieslik1,2, Xiaoye Xia3, Ali Salehi-Reyhani1,3
1Department of Surgery & Cancer, Imperial College London, London, W12 0HS, UK. ali.salehi-reyhani@imperial.ac.uk.
Lab on a chip
|February 12, 2026
概括
使用机器引导光学针 (MaGIC-OT) 自动化罕见细胞隔离可增强液体活检. 这种人工智能驱动的平台提高了分离循环瘤细胞 (CTC) 的速度和成功率.
科学领域:
- 生物医学工程 生物医学工程
- 细胞生物学 细胞生物学
- 人工智能的人工智能
背景情况:
- 自动化罕见细胞隔离,例如循环瘤细胞 (CTC),对于液体活检至关重要,但在微流体设备中仍然具有挑战性.
- 光学子提供精确的,非接触式细胞操纵,但通常需要专家操作.
研究的目的:
- 开发一个自动化的平台,MAGIC-OT (使用光学子引导细胞的机器隔离),用于微流体学中的单细胞操纵.
- 集成经典路径规划和深度强化学习 (DRL) 来实现自主光学笔控制.
主要方法:
- 开发了一个高保真模拟环境,用于训练和评估光学子的DRL控制政策.
- 员工合作,人为循环培训,以提高DRL代理商的性能.
- 集成的MaGIC-OT与微流体芯片用于芯片上的细胞隔离.
主要成果:
- 训练有素的DLR代理人表现出优越的速度和隔离成功率,与的专家用户相比.
- 通过使用MaGIC-OT平台,成功地将癌细胞从的血液样本中分离出来.
- 通过合作,人-in-the-loop培训,展示了通过合作,人-in-the-loop培训提高DRL性能.
结论:
- 在微流体学中,MAGIC-OT为自动光学操纵提供了灵活,智能框架.
- 该平台将自主控制与微流体设备设计结合起来,用于先进的细胞隔离.
- 为液体活检提供了通往高纯度,无标签单细胞隔离工作流的有希望的途径.
相关概念视频
01:29Magical Thinking
228
Magical thinking encompasses the belief in assumptions that defy logical reasoning yet appear intuitively convincing. It is a common psychological phenomenon that persists across various cultural and individual contexts. While these assumptions contradict empirical evidence and scientific laws, they often serve meaningful psychological roles in promoting emotional resilience and a sense of control, especially under stress or uncertainty.Thought-Action Fusion and the Law of SimilarityA key...
228
01:22Autonomic Nervous System
13.0K
The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
13.0K
01:26Autonomic Nervous System: Overview
7.6K
The human nervous system is divided into two main parts: the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS is composed of the brain and spinal cord, while the PNS contains nerve cells, clusters of nerve cells, and the sensory receptors that are outside the CNS. The PNS has two types of nerve cells: sensory (afferent) and motor (efferent). Sensory cells send signals to the CNS from receptors, and motor cells carry signals from the CNS to organs, muscles, and...
7.6K
01:18Disorders of the Autonomic Nervous System
1.6K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
1.6K
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.1K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.1K
01:28Drugs Acting on Autonomic Ganglia: Blockers
1.7K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.7K